mAbxience and Sandoz sign deal for emicizumab biosimilar candidate
mAbxience will handle development and manufacturing, while Sandoz takes exclusive commercialization rights everywhere…
Latest news
Everything we have published, most recent first.
452 stories Page 26 of 38
SK hynix launches AI-focused venture capital brand in Silicon Valley
The chipmaker says it will widen its corporate venture arm beyond semiconductors to AI computing, data centers, system…
iQIYI Ties Its Growth Outlook to Big-Screen Viewing
The platform points to connected-TV data and its own smart TV app figures as evidence that long-form video is shifting…
Ten years, seven hundred million trees: The slow project that paid off
Arcjet launches runtime security for AI agents in production
The product combines observe, enforce and audit capabilities across agent workflows, and the company's JavaScript…
NovoLINC launches MaxLINC thermal material for multi-kilowatt AI chips
The Pittsburgh company says the thermal interface material reaches resistance as low as 0.7 mm²·K/W and is moving into…
Insilico Medicine releases open AI toolkit for aging research
A Cell cover study from the company introduces an open benchmark, a family of compact language models and an agentic…
Inductive launches Beacon-2 to compute human dose from structure
The system estimates the efficacious human dose of a small molecule before it is made, the company says.
Geekplus opens first European innovation lab in Düsseldorf
The company says the facility is expected to welcome more than 1,000 visitors a year and will display systems including…
Tencent Cloud named a Leader in IDC managed edge services assessment
The company said EdgeOne was cited for combining acceleration, security and edge AI capabilities on one platform, as…
transcosmos named a Leader for sixth straight year in Everest Group APAC CXM assessment
The Tokyo-based services company said the 2026 study of Asia Pacific customer experience providers again placed it in…
Japan approves Lundbeck's eptinezumab for migraine prevention
Japan's health ministry has granted marketing authorization for the intravenous migraine preventive, which Lundbeck…